The certified manufacturing process of collprotect® membrane ensures the removal of cells, non-collagenous proteins and potential immunogenic components including bacteria and viruses. The intense purification process includes defatting of the tissue and treatment with different chemical agents that are used to eliminate possible pathogens as well as cellular and potentially immunogenic components. Following lyophilization, the end product is sterilized by gamma irradiation. Therefore, this membrane is a safe medical device that is regulated according to the EC guidelines with a standardized manufacturing process based on international standards (EN ISO13485).
Author: megagen
Safe and Sterile
After a thorough analysis of the donors’ medical history, the high safety of maxgraft® is ensured by a series of stringent serological tests in combination with C+TBA’s Allotec® purification process and final radiological sterilization.
C+TBA is certified as a tissue procurement facility and tissue bank according to §19 and §22 of the Austrian Tissue Safety Act.
Origin
maxgraft® is processed allograft from human donors. maxgraft® bonebuilder is precisely milled by C+TBA from cancellous bone blocks. The cancellous blocks originate from femoral heads of living donors donated during hip arthroplasty surgery. Procurement is standardized according to a predefined protocol and is performed by certified procurement centers. All tissue donations are made only after the donor has given written consent. In addition, the health status of each potential donor is assessed in advance as part of a risk analysis and the donor is then selected on the basis of strict exclusion criteria.
Rehydration
The maxgraft® production process preserves the natural collagen and a residual moisture of <10%. Nevertheless, rehydration is recommended (10 minutes in physiological saline solution). Rehydration can improve the adaptability of the material (especially with large blocks) to the defect.
Valid Alternative to Patient’s Own Bone
maxgraft® bonebuilder enables complex horizontal and vertical augmentation without burdening the patient by using autologous bone. Due to its high biological regenerative capacity and complete remodeling, maxgraft® bonebuilder represents an alternative to the patient’s own bone block1. The need for a second surgical site is eliminated, surgical time is shortened, and postoperative pain and morbidity for the patient are significantly reduced.
Early Implantation
According to the early implantation procedure, the implant is placed after tooth extraction, before the bony regeneration takes place within the socket. Typically, an early implantation is performed about 4-8 weeks after tooth extraction; at this point, the healing of the soft tissue is completed and potential inflammations have disappeared. The natural healing of the socket may be supported by applying collacone® into the socket to support the stabilization of the formed blood coagulum and protect the wound area from food and bacteria. Although the bone volume is usually adequate after 4-8 weeks (since the resorption of the alveolar bone has not yet started), any existing bony defect of the alveolus may be treated at the moment of implantation.
Rapid Uptake of Blood and Liquids
Due to its hydrophilic properties and highly porous structure, collacone® quickly absorbs blood. High resolution pictures show the spongy structure fiber network of collacone®.
Application of Collacone®
Generally, dry application of collacone® is recommended, because soaking or moistening prior to implantation may impair its hemostatic properties. At the defect site, the spongy cone rapidly soaks up blood. The collacone® maintains integrity in the presence of blood and during application.
Protection of the Socket and Blood Clot
The form-fitted cone shape of collacone® protects the wound area from entry of food and bacteria. Furthermore, the spongy collagen structure of the cone encourages coagulum formation and provides an ideal structure for the adhesion of thrombocytes, fibroblasts and osteoblasts. Fine blood vessels grow into and through the cone, connecting it to the surrounding tissue. Consequently, the preliminary tissue formed in the alveolus is supplied with oxygen and nutrients and important signaling molecules supporting its bony regeneration.
Prevention of Bleeding in Hemostatic Compromised Patients
Medication with anticoagulant drugs (i.e. heparin or warfarin) poses a higher risk for patients of bleeding following tooth extraction. Local hemostatic agents like collagen fleeces can prevent postoperative bleeding without the need to pause the anticoagulant therapy. A retrospective study with 200 anticoagulated patients showed a very low rate of bleedings following application of collacone® in fresh extraction sockets